Accordingly, transgenic mice overexpressing SIRT1 are protected against various metabolic disorders, including glucose intolerance, high-fat diet (HFD)-induced fatty liver, type 2 diabetes [94], age-induced cancer, osteoporosis, and cardiac hypertrophy [11]. Here, SIRT1 is linked to fatty liver disease.